Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 21;10(18):e021622.
doi: 10.1161/JAHA.121.021622. Epub 2021 Sep 17.

Outcomes of Echocardiography-Detected Rheumatic Heart Disease: Validating a Simplified Score in Cohorts From Different Countries

Collaborators, Affiliations

Outcomes of Echocardiography-Detected Rheumatic Heart Disease: Validating a Simplified Score in Cohorts From Different Countries

Bruno R Nascimento et al. J Am Heart Assoc. .

Abstract

Background The natural history of latent rheumatic heart disease (RHD) detected by echocardiography remains unclear. We aimed to assess the accuracy of a simplified score based on the 2012 World Heart Federation criteria in predicting mid-term RHD echocardiography outcomes in children from 4 different countries. Methods and Results Patient-level baseline and follow-up data of children with latent RHD from 4 countries (Australia, n=62; Brazil, n=197; Malawi, n=40; New Zealand, n=94) were combined. A simplified echocardiographic scoring system previously developed from Brazilian and Ugandan cohorts, consisting of 5 point-based variables with respective weights, was applied: mitral valveanterior leaflet thickening (weight=3), excessive leaflet tip motion (3), regurgitation jet length ≥2 cm (6), aortic valve focal thickening (4), and any regurgitation (5). Unfavorable outcome was defined as worsening diagnostic category, persistent definite RHD or development/worsening of valve regurgitation/stenosis. The score model was updated using methods for recalibration. 393 patients (314 borderline, 79 definite RHD) with median follow-up of 36 (interquartile range, 25-48) months were included. Median age was 14 (interquartile range, 11-16) years and secondary prophylaxis was prescribed to 16%. The echocardiographic score model applied to this external population showed significant association with unfavorable outcome (hazard ratio, 1.10; 95% CI, 1.04-1.16; P=0.001). Unfavorable outcome rates in low (≤5 points), intermediate (6-9), and high-risk (≥10) children at 3-year follow-up were 14.3%, 20.8%, and 38.5% respectively (P<0.001). The updated score model showed good performance in predicting unfavorable outcome. Conclusions The echocardiographic score model for predicting RHD outcome was updated and validated for different latent RHD populations. It has potential utility in the clinical and screening setting for risk stratification of latent RHD.

Keywords: echocardiography; follow‐up; prognosis; rheumatic heart disease; screening.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1. Plotted predicted‐to‐observed adverse outcome for the (A) total sample and for (B) each risk score group in the pooled population after recalibration.
Figure 2
Figure 2. Receiver operator characteristic curve for echocardiographic score showing predicted probability of unfavorable echo outcome from the model (area under the curve=0.70). AUC indicates area under the curve.
Figure 3
Figure 3. Cumulative survival free of unfavorable outcome in children with echocardiography‐detected rheumatic heart disease according to 3 risk categories: low‐risk (0–6 points), intermediate risk (7–9 points), and high‐risk (≥10 points) of the simplified score, with results of the Cox proportional analysis.

References

    1. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd‐Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7 - DOI - PMC - PubMed
    1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010 - DOI - PMC - PubMed
    1. Kotit S, Said K, ElFaramawy A, Mahmoud H, Phillips DIW, Yacoub MH. Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease. Open Heart. 2017;4:e000702. doi: 10.1136/openhrt-2017-000702 - DOI - PMC - PubMed
    1. Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, Yacoub MH, Zuhlke LJ. Rheumatic heart disease worldwide: JACC scientific expert panel. J Am Coll Cardiol. 2018;72:1397–1416. doi: 10.1016/j.jacc.2018.06.063 - DOI - PubMed
    1. Diamantino A, Beaton A, Aliku T, Oliveira K, Oliveira C, Xavier L, Perlman L, Okello E, Nascimento B, Ribeiro ARP, et al. A focussed single‐view hand‐held echocardiography protocol for the detection of rheumatic heart disease. Cardiol Young. 2018;28:108–117. doi: 10.1017/S1047951117001676 - DOI - PubMed

Publication types

LinkOut - more resources